|
1
|
Kjellev S: The trefoil factor family-small
peptides with multiple functionalities. Cell Mol Life Sci.
66:1350–1369. 2009.PubMed/NCBI
|
|
2
|
Aihara E, Engevik KA and Montrose MH:
Trefoil factor peptides and gastrointestinal function. Annu Rev
Physiol. 79:357–380. 2017.PubMed/NCBI
|
|
3
|
Sun Z, Liu H, Yang Z, Shao D, Zhang W, Ren
Y, Sun B, Lin J, Xu M and Nie S: Intestinal trefoil factor
activates the PI3K/Akt signaling pathway to protect gastric mucosal
epithelium from damage. Int J Oncol. 45:1123–1132. 2014.PubMed/NCBI
|
|
4
|
Huynh E and Li J: Generation of
lactococcus lactis capable of coexpressing epidermal growth factor
and trefoil factor to enhance in vitro wound healing. Appl
Microbiol Biotechnol. 99:4667–4677. 2015.PubMed/NCBI
|
|
5
|
Fabisiak A, Bartoszek A, Kardas G,
Fabisiak N and Fichna J: Possible application of trefoil factor
family peptides in gastroesophageal reflux and Barrett's esophagus.
Peptides. 115:27–31. 2019.PubMed/NCBI
|
|
6
|
Jeffrey GP, Oates PS, Wang TC, Babyatsky
MW and Brand SJ: Spasmolytic polypeptide: A trefoil peptide
secreted by rat gastric mucous cells. Gastroenterology.
106:336–345. 1994.PubMed/NCBI
|
|
7
|
Lin N, Xu LF and Sun M: The protective
effect of trefoil factor 3 on the intestinal tight junction barrier
is mediated by toll-like receptor 2 via a PI3K/Akt dependent
mechanism. Biochem Bioph Res Commun. 440:143–149. 2013.
|
|
8
|
Scholven J, Taras D, Sharbati S, Schon J,
Gabler C, Huber O, Meyer zum Büschenfelde D, Blin N and Einspanier
R: Intestinal expression of TFF and related genes during postnatal
development in a piglet probiotic trial. Cell Physiol Biochem.
23:143–156. 2009.PubMed/NCBI
|
|
9
|
Graziani F, Pinton P, Olleik H, Pujol A,
Nicoletti C, Sicre M, Quinson N, Ajandouz EH, Perrier J, Pasquale
ED, et al: Deoxynivalenol inhibits the expression of trefoil
factors (TFF) by intestinal human and porcine goblet cells. Arch
Toxicol. 93:1039–1049. 2019.PubMed/NCBI
|
|
10
|
Heo JM, Opapeju FO, Pluske JR, Kim JC,
Hampson DJ and Nyachoti CM: Gastrointestinal health and function in
weaned pigs: A review of feeding strategies to control post-weaning
diarrhoea without using in-feed antimicrobial compounds. J Anim
Physiol an N. 97:207–237. 2013.
|
|
11
|
Pluske JR, Turpin DL and Kim JC:
Gastrointestinal tract (gut) health in the young pig. Anim Nutr.
4:187–196. 2018.PubMed/NCBI
|
|
12
|
Meyer zum Buschenfelde D, Hoschutzky H,
Tauber R and Huber O: Molecular mechanisms involved in TFF3
peptide-mediated modulation of the E-cadherin/catenin cell adhesion
complex. Peptides. 25:873–883. 2004.PubMed/NCBI
|
|
13
|
Durer U, Hartig R, Bang S, Thim L and
Hoffmann W: TFF3 and EGF induce different migration patterns of
intestinal epithelial cells in vitro and trigger increased
internalization of E-cadherin. Cell Physiol Biochem. 20:329–346.
2007.PubMed/NCBI
|
|
14
|
Paulsen FP, Woon CW, Varoga D, Jansen A,
Garreis F, Jager K, Amm M, Podolsky DK, Steven P, Barker NP and Sel
S: Intestinal trefoil factor/TFF3 promotes re-epithelialization of
corneal wounds. J Biol Chem. 283:13418–13427. 2008.PubMed/NCBI
|
|
15
|
Jiang GX, Zhong XY, Cui YF, Liu W, Tai S,
Wang ZD, Shi YG, Zhao SY and Li CL: IL-6/STAT3/TFF3 signaling
regulates human biliary epithelial cell migration and wound healing
in vitro. Mol Biol Rep. 37:3813–3818. 2010.PubMed/NCBI
|
|
16
|
Manko A, Motta JP, Cotton JA, Feener T,
Oyeyemi A, Vallance BA, Wallace JL and Buret AG: Giardia
co-infection promotes the secretion of antimicrobial peptides
beta-defensin 2 and trefoil factor 3 and attenuates attaching and
effacing bacteria-induced intestinal disease. PLoS One.
12:e01786472017.PubMed/NCBI
|
|
17
|
Nakov R, Velikova T, Nakov V, Ianiro G,
Gerova V and Tankova L: Serum trefoil factor 3 predicts disease
activity in patients with ulcerative colitis. Eur Rev Med Pharmacol
Sci. 23:788–794. 2019.PubMed/NCBI
|
|
18
|
Soriano-Izquierdo A, Gironella M,
Massaguer A, May FE, Salas A, Sans M, Poulsom R, Thim L, Pique JM
and Panes J: Trefoil peptide TFF2 treatment reduces VCAM-1
expression and leukocyte recruitment in experimental intestinal
inflammation. J Leukoc Biol. 75:214–223. 2004.PubMed/NCBI
|
|
19
|
Lin J, Holzman IR, Jiang P and Babyatsky
MW: Expression of intestinal trefoil factor in developing rat
intestine. Biol Neonate. 76:92–97. 1999.PubMed/NCBI
|
|
20
|
Fang M, Wang W, Wang Y and Ru B: Bacterial
expression and purification of biologically active human TFF3.
Peptides. 25:785–792. 2004.PubMed/NCBI
|
|
21
|
Lu R, Wang X, Chen JP, Chen X and Xu JN:
Expression of human TFF3 in Escherichia coli. Sichuan Da Xue Xue
Bao Yi Xue Ban. 41:114–117. 2010.(In Chinese). PubMed/NCBI
|
|
22
|
Wang H, Tong Y, Fang M and Ru B:
High-level expression of human TFF3 in Escherichia coli. Peptides.
26:1213–1218. 2005.PubMed/NCBI
|
|
23
|
Mizukami M, Hanagata H and Miyauchi A:
Brevibacillus expression system: Host-vector system for efficient
production of secretory proteins. Curr Pharm Biotechnol.
11:251–258. 2010.PubMed/NCBI
|
|
24
|
Tokunaga M, Mizukami M, Yamasaki K,
Tokunaga H, Onishi H, Hanagata H, Ishibashi M, Miyauchi A, Tsumoto
K and Arakawa T: Secretory production of single-chain antibody
(scFv) in Brevibacillus choshinensis using novel fusion partner.
Appl Microbiol Biot. 97:8569–8580. 2013.
|
|
25
|
Uenishi H, Eguchi T, Suzuki K, Sawazaki T,
Toki D, Shinkai H, Okumura N, Hamasima N and Awata T: PEDE (Pig EST
Data Explorer): Construction of a database for ESTs derived from
porcine full-length cDNA libraries. Nucleic Acids Res. 1:D484–D488.
2004.
|
|
26
|
Kondo S, Araki T, Toiyama Y, Tanaka K,
Kawamura M, Okugawa Y, Okita Y, Saigusa S, Inoue Y, Uchida K, et
al: Downregulation of trefoil factor-3 expression in the rectum is
associated with the development of ulcerative colitis-associated
cancer. Oncol Lett. 16:3658–3664. 2018.PubMed/NCBI
|
|
27
|
Gao F, Pan SX, Liu B and Zhang HZ: TFF3
knockout in human pituitary adenoma cell HP75 facilitates cell
apoptosis via mitochondrial pathway. Int J Clin Exp Patho.
8:14568–14573. 2015.
|
|
28
|
Arnold P, Rickert U, Helmers AK, Spreu J,
Schneppenheim J and Lucius R: Trefoil factor 3 shows
anti-inflammatory effects on activated microglia. Cell Tissue Res.
365:3–11. 2016.PubMed/NCBI
|
|
29
|
Große-Kreul J, Busch M, Winter C, Pikos S,
Stephan H and Dunker N: Forced trefoil factor family peptide 3
(TFF3) expression reduces growth, viability, and tumorigenicity of
human retinoblastoma cell lines. PLoS One.
11:e01630252016.PubMed/NCBI
|
|
30
|
Bastholm SK, Samson MH, Becher N, Hansen
LK, Stubbe PR, Chronakis IS, Nexo E and Uldbjerg N: Trefoil factor
peptide 3 is positively correlated with the viscoelastic properties
of the cervical mucus plug. Acta Obstet Gyn Scan. 96:47–52.
2017.
|
|
31
|
Li Q, Wang KK, Su C and Fang JY: Serum
trefoil factor 3 as a protein biomarker for the diagnosis of
colorectal cancer. Technol Cancer Res T. 16:440–445. 2017.
|
|
32
|
Al-Salam S, Sudhadevi M, Awwad A and Al
Bashir M: Trefoil factors peptide-3 is associated with residual
invasive breast carcinoma following neoadjuvant chemotherapy. Bmc
Cancer. 19:1352019.PubMed/NCBI
|
|
33
|
Mizukami M, Onishi H, Hanagata H, Miyauchi
A, Ito Y, Tokunaga H, Ishibashi M, Arakawa T and Tokunaga M:
Efficient production of Trastuzumab Fab antibody fragments in
Brevibacillus choshinensis expression system. Protein Expres Purif.
150:109–118. 2018.
|
|
34
|
Mizukami M, Tokunaga H, Onishi H, Ueno Y,
Hanagata H, Miyazaki N, Kiyose N, Ito Y, Ishibashi M, Hagihara Y,
et al: Highly efficient production of VHH antibody fragments in
Brevibacillus choshinensis expression system. Protein Expres Purif.
105:23–32. 2015.
|
|
35
|
Hu W, Xiang JY, Kong P, Liu L, Xie QH and
Xiang HY: Expression and characterization of a single-chain
variable fragment against human LOX-1 in Escherichia coli and
Brevibacillus choshinensis. J Microbiol Biotechn. 27:965–974.
2017.
|
|
36
|
Zou C, Duan XG and Wu J: Efficient
extracellular expression of Bacillus deramificans pullulanase in
Brevibacillus choshinensis. J Ind Microbiol Biot. 43:495–504.
2016.
|
|
37
|
Cheng YM, Lu MT and Yeh CM: Functional
expression of recombinant human trefoil factor 1 by Escherichia
coli and Brevibacillus choshinensis. Bmc Biotechnol.
15:322015.PubMed/NCBI
|
|
38
|
Hanagata H and Mizukami M: Production of
recombinant CCN proteins by Brevibacillus choshinensis. Methods Mol
Biol. 1489:85–93. 2017.PubMed/NCBI
|
|
39
|
Li Z, Su L, Duan X, Wu D and Wu J:
Efficient expression of maltohexaose-forming α-amylase from
Bacillus stearothermophilus in Brevibacillus
choshinensis SP3 and its use in maltose production. Biomed Res Int.
2017:54797622017.PubMed/NCBI
|
|
40
|
Panfertsev EA, Baranova EV, Mochalov VV,
Soloviev PV, Gorbatov AA and Biketov SF: Construction of
recombinant strain Brevibacillus choshinensis for chimeric borrelia
Dbpa antigen production. Klin Lab Diagn. 63:450–454. 2018.(In
Russian). PubMed/NCBI
|
|
41
|
Duan X, Shen Z, Zhang X, Wang Y and Huang
Y: Production of recombinant beta-amylase of Bacillus aryabhattai.
Prep Biochem Biotech. 49:88–94. 2019.
|
